As a side effect of globalisation, disease outbreaks can spread rapidly and easily cross borders and continents, having a catastrophic impact on health, society, and economy globally, which requires appropriate and effective measures to contain the spread of any deadly infection. The COVID-19 pandemic have culminated the attention towards the spread of harmful pathogens, which is often facilitated by high traffic surfaces. In response, surfaces and coatings that are capable of minimizing the presence of active viral pathogens, or other pathogens such as microbes and fungi – especially if applied in certain settings such as objects in public places, public transport, hospitals, public buildings, schools and various businesses – offer a great potential to reduce human exposure and mitigate the spread of infectious pathogens. Therefore, developing antimicrobial surface coatings, either minimising the surface adhesion of pathogens, introducing antimicrobial actions, or a synergistic effect, has emerged as a major global strategy to fight the spread of disease outbreaks.
Nanoparticle (NP) filled coatings, with recognised effectiveness against bacteria, viruses, and fungi, are valuable candidates for developing antimicrobial surface and minimising the surface adhesion of pathogens. However, due to the many technical challenges, including difficulty to develop nanocoatings with a long-term antimicrobial capability, durability under real conditions and safety assurance, their application at industrial level is still limited.